HUM
46
-3
IFF
60
-2
EQT
40
-16
EQIX
57
-6
APH
43
-3
VLO
26
-13
AVB
67
-3
RSG
59
-6
VNO
56
-3
HRL
36
3
TXN
33
-3
YUM
43
-2
RHI
42
-2
AMG
30
-3
TRV
65
-2
NSC
65
-5
PWR
48
-4
CSCO
37
-4
D
58
-2
CAT
51
-2
HUM
46
-3
IFF
60
-2
EQT
40
-16
EQIX
57
-6
APH
43
-3
VLO
26
-13
AVB
67
-3
RSG
59
-6
VNO
56
-3
HRL
36
3
TXN
33
-3
YUM
43
-2
RHI
42
-2
AMG
30
-3
TRV
65
-2
NSC
65
-5
PWR
48
-4
CSCO
37
-4
D
58
-2
CAT
51
-2
Financhill
Back

Axsome Therapeutics Quote, Financials, Valuation and Earnings

Fed rate cuts could send the stock market down

Here's my #1 free indicator to use now.
Sell
47

AXSM
Axsome Therapeutics

Last Price:
93.17
Seasonality Move:
12.35%

7 Day Trial

ALL ACCESS PASS

$ 7

#1 free indicator forecasts the next market drop here

Discover my #1 trading indicator here.

Axsome Therapeutics Price Quote

$93.17
+0.04 (+-0.56%)
(Updated: September 7, 2024 at 6:22 AM ET)

Axsome Therapeutics Key Stats

Sell
47
Axsome Therapeutics (AXSM) is a Sell
Day range:
$91.52 - $94.53
52-week range:
$55.02 - $98.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.13
P/B ratio:
43.46%
Volume:
370.3K
Avg. volume:
459.3K
1-year change:
14.23%
Market cap:
$4.5B
Revenue:
$270.6M
EPS:
$-6.51

How Much Does Axsome Therapeutics Make?

Is Axsome Therapeutics Growing As A Company?

  • What Is Axsome Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.87%
  • What Is Axsome Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Axsome Therapeutics Stock Price Performance

What Is Axsome Therapeutics 52-Week High & Low?

Axsome Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Axsome Therapeutics?

Is Axsome Therapeutics Cash Flow Positive?

  • What Is AXSM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$167.5M
  • What Is Axsome Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $46.6M
  • What Is Axsome Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$528K

Axsome Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    AXSM return on invested capital is -82.21%
  • What Is Axsome Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -53.3%
  • What Is AXSM Return On Equity?
    ROE is a measure of profitability and is -156.44%

Axsome Therapeutics Earnings Date & Stock Price

Axsome Therapeutics Competitors

  • Who Are Axsome Therapeutics's Competitors?
    Below is a list of companies who compete with Axsome Therapeutics or are related in some way:
    • Krystal Biotech Inc (KRYS)
    • Eli Lilly and Co (LLY)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • Sarepta Therapeutics Inc (SRPT)
    • Vertex Pharmaceuticals Inc (VRTX)

Axsome Therapeutics Dividend Yield

Axsome Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.84%
Revenue: 86.65% 0.27%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 125.24
Upside from Last Price: 34.47%

Major Shareholders

  • How many AXSM shares are owned by institutional investors?
    56.8M AXSM shares are owned by institutional investors
  • How many AXSM shares are owned by insiders?
    209.5K AXSM shares are owned by insiders